[
1. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr, 2013;102(8):787-96.10.1111/apa.12266
]Search in Google Scholar
[
2. Blizzard RM. History of growth hormone therapy. Indian J Pediatr, 2012;79(1):87-91.10.1007/s12098-011-0609-4
]Search in Google Scholar
[
3. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr, 1985;107(1):10-2.10.1016/S0022-3476(85)80604-1
]Search in Google Scholar
[
4. Peneva L. Hyposomatotropism in childhood and adolescence, Dissertation, Medical Academy -Sofia, 1984;191-83.
]Search in Google Scholar
[
5. Peneva L, Kazakova K, Stefanova E, Stoeva I. Treatment of children with hyposomatotropism with recombinant human growth hormone Norditropin. Paediatrics, 1996;36-41.
]Search in Google Scholar
[
6. Iotova V. Effect of low weight and short stature at birth on postnatal growh and some markers of increased cardiovascular and metabolic risk in adolescents, Dissertation, Medical University -Varna, 2003.
]Search in Google Scholar
[
7. Brook CGD, Clayton P, Brown R, Brook’s Clinical Pediatric Endocrinology. 2011: Wiley.10.1002/9781119968153
]Search in Google Scholar
[
8. Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr, 2016;86(6):361-97.10.1159/000452150
]Search in Google Scholar
[
9. Iotova V. Evaluation of growth in routine outpatient and clinical settings. Paediartic practice, 2004;4:7-8.
]Search in Google Scholar
[
10. Stanimirova N. Growth and development in adolescence: normal ranges and deviations. Dissertation, Medical University - Pleven, 1998.
]Search in Google Scholar
[
11. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur. J. Clin. Nutr, 1991;45(1):13-21.
]Search in Google Scholar
[
12. Darendeliler F, Lindberg A Wilton P. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency. Horm Res Paediatr, 2011;76 Suppl 1:42-6.10.1159/000329161
]Search in Google Scholar
[
13. Antoniazzi F, Cavarzere P, Gaudino R. Growth hormone and early treatment. Minerva Endocrinol, 2015;40(2):129-43.
]Search in Google Scholar
[
14. Rappaport R, Mugnier Е, Limoni C, Crosnier H, Czernichow P, Leger J et al. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. J. Clin. Endocrinol. Metab, 1997;82(2):452-6.
]Search in Google Scholar
[
15. Stagi S, Scalini P, Farello G, Verrotti A. Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art. Ital. J. Pediatr, 2017;43(1):81.
]Search in Google Scholar
[
16. Thomas M, Massa G, Craen M, de Zegher F, Bourguignon JP, Heinrichs C et al. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001. Eur. J. Endocrinol, 2004;151(1):67-72.
]Search in Google Scholar
[
17. Lindsay R, Feldkamp M, Harris D, Robertson, Rallison J. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J. Pediatr, 1994;125(1):29-35.10.1016/S0022-3476(94)70117-2
]Search in Google Scholar
[
18. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS et al. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J. Clin. Endocrinol. Metab, 2013;98(6):E1072-E87.10.1210/jc.2012-3888378988623543664
]Search in Google Scholar
[
19. Tsochev K, Stoycheva R, Iotova V, Karamfilova T, Markovska V, Halvadjian I et al. Results from the Implementation of a 2 Year Growth Awareness and Growth Disorders Screening Campaign (GrowInform). in 58th Annual ESPE. 2019. European Society for Paediatric Endocrinology.
]Search in Google Scholar
[
20. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab, 2006;91(10):3897-902.10.1210/jc.2006-055816849410
]Search in Google Scholar
[
21. Maghnie M, Lindberg A, Koltowska-Haggstrom M Ranke MB. Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol, 2013;168(2):211-7.10.1530/EJE-12-080123152438
]Search in Google Scholar
[
22. Collett-Solberg PF, Jorge AA, Boguszewski MC, Miller BS, Choong CSY, Cohen P et al. Growth hormone therapy in children; research and practice–A review. Growth Horm IGF Res, 2019;44:20-32.10.1016/j.ghir.2018.12.00430605792
]Search in Google Scholar
[
23. Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS et al. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr, 2019:1-14.10.1159/000502231697944331514194
]Search in Google Scholar
[
24. Parra A, Argote RM, García G, Cervantes C, Alatorre S, Pérez-Pasten E. Body composition in hypopituitary dwarfs before and during human growth hormone therapy. Metab.: Clin. Exp, 1979;28(8):851-7.
]Search in Google Scholar
[
25. Boot AM, Engels MA, Boerma GJ, Krenning EP de Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J. Clin. Endocrinol. Metab, 1997;82(8):2423-8.
]Search in Google Scholar
[
26. Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab, 2010;95(3):1131-6.10.1210/jc.2009-1389284153720061431
]Search in Google Scholar
[
27. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG and A.N.C.T. Group. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J. Clin. Endocrinol. Metab, 2002;87(1):90-8.
]Search in Google Scholar
[
28. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol, 2007;157(6):695-700.10.1530/EJE-07-063118057375
]Search in Google Scholar
[
29. Akaltun I, Cayir A, Kara T Ayaydin H. Is growth hormone deficiency associated with anxiety disorder and depressive symptoms in children and adolescents?: A case-control study. Growth Horm IGF Res, 2018;41:23-7.10.1016/j.ghir.2018.06.00129886327
]Search in Google Scholar
[
30. Silva N, Bullinger M, Sommer R, Rohenkohl A, Witt S Quitmann J. Children’s psychosocial functioning and parents’ quality of life in paediatric short stature: The mediating role of caregiving stress. Clin Psychol Psychother, 2018;25(1):e107-e18.10.1002/cpp.214628960605
]Search in Google Scholar
